Perceived risk for Type 2 diabetes in participants in a stepwise population-screening programme

Diabetic Medicine

Volumn 20, Issue 3, 2003, Pages 210-215

  Adriaanse, Marcel C ^a,b   Snoek, F J ^a,b   Dekker, J M ^a   Spijkerman, A M W ^a   Nijpels, G ^a   Van Der Ploeg, H M ^a,b   Heine, R J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Risk perception; Screening; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERCEPTION; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCREENING;

AGED; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT PARTICIPATION; PERCEPTION; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 0037349246     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00901.x     Document Type: Article

References (25)

1. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
2. American Diabetes Association. Screening for diabetes (Position Statement). Diabetes Care 2002; S21-S24.
3. Tuomiletho J, Tuomiletho-Wolf E, Zimmet P, Alberti K, Knowler W. Primary prevention of diabetes mellitus. In: International Textbook of Diabetes Mellitus. Chichester: John Wiley, 1997; 1799-1827.
4. Glasgow RE, Fisher EB, Anderson BJ, LaGreca A, Marrero D, Johnson SB et al. Behavioral science in diabetes. Contributions and opportunities. Diabetes Care 1999; 22: 832-843.
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
7. American Diabetes Association. Standards for medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 2002; S33-S49.
8. Slovic P. The Perception of Risk. London: Earthscan, 2001.
9. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q 1984; 11: 1-47.
10. Leventhal H, Benyamini Y, Brownlee S, Dietenbach M, Leventhal E, Patrich-Miller L et al. Illness representations: theoretical foundations. In Petrie KJ, Weinman JA eds. Perceptions of Health and Illness. Amsterdam, Netherlands: Harwood Academic Publishers 1997; 19-45.
11. Glasgow RE, Hampson SE, Strycker LA, Ruggiero L. Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care 1997; 20: 556-561.
12. Duncan B, Hart G, Scoular A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ 2001; 322: 195-199.
13. White MP, Riazi A, Eiser C, Hammersley S, Eiser JR, MacLeod K et al. Interpreting the risks of diabetic renal disease: perspectives of those most at risk. Psychol Health 2002; 17: 33-50.
14. Polley BA, Jakicic JM, Venditti EM, Barr S, Wing RR. The effects of health beliefs on weight loss in individuals at high risk for NIDDM. Diabetes Care 1997; 20: 1533-1538.
15. Harwell TS, Dettori N, Flook BN, Priest L, Williamson DF, Helgerson SD et al. Preventing type 2 diabetes: perceptions about risk and prevention in a population-based sample of adults > or = 45 years of age. Diabetes Care 2001; 24: 2007-2008.
16. Spijkerman AMW, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM et al. Diabetic patients detected by population-based stepwise screening already have a 'diabetic' cardiovascular risk profile. Diabetes Care 2002; 25: 1784-1789.
17. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20: 491-496.
18. Lloyd AJ. The extent of patients' understanding of the risk of treatments. Qual Health Care Supplement 2001; 1: i14-18.
19. Reyna VF, Lloyd FJ, Brainerd CJ. Memory, development, and rationality: an integrative theory of judgment and decision-making. In Schneider S, Shanteau J eds. Emerging Perspectives in Judgment and Decision Making. New York: Oxford University Press, in press.
20. Adriaanse MC, Snoek FJ, Dekker JM, van der Ploeg HM, Heine RJ. Screening for Type 2 diabetes: an exploration of subjects' perceptions regarding diagnosis and procedure. Diabet Med 2002; 19: 406-411.
21. Ransford HE. Race, heart disease worry and health protective behavior. Soc Sci Med 1986; 22: 1355-1362.
22. Lewis KS, Jennings AM, Ward JD, Bradley C. Health belief scales developed specifically for people with tablet-treated type 2 diabetes. Diabet Med 1990; 7: 148-155.
23. Farmer AJ, Levy JC, Turner RC. Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients. Diabet Med 1999; 16: 233-237.
24. Hunt K, Davison C, Emslie C, Ford G. Are perceptions of a family history of heart disease related to health-related attitudes and behaviour? Health Educ Res 2000; 15: 131-143.
25. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ 2001; 322: 1056-1059.